Extracellular matrix metabolism in chondrocytes reflects early osteoarthritis patterns when reared in diluted synovial fluid: Implications for exploratory arthroscopy
Location
Philadelphia, PA
Start Date
17-4-2026 1:30 PM
End Date
17-4-2026 2:30 PM
Description
INTRODUCTION: Arthroscopy is the standard of care and a minimally invasive procedure for diagnosing joint pathologies. But very few studies have been conducted to determine whether procedural conditions may alter chondrocytes in ways that can lead to osteoarthritis (OA). During the procedure, changes occur in the cartilage microenvironment, including diluting the synovial fluid with saline to improve field visibility.
OBJECTIVE: The fundamental question then is whether these temporary conditions contribute to cellular and metabolic changes consistent with early OA pathogenesis and whether concurrent pharmacological intervention can alter this damage.
METHODS: To address the challenge of studying cellular-level effects in vitro, our lab optimized a three-dimensional, serum-free tissue culture model for primary human articular chondrocytes (HC-a) encapsulated in alginate beads at a density of 1.5 x 106 cells/mL of alginate that recreates the cartilage environment. We reared HC-a in varying dilutions of artificial synovial fluid (ASF) and measured key extracellular matrix (ECM) proteins in the secreted (S), ECM-associated (E), and cell-associated (C) fractions. Cells were incubated for 24 hours with 100% ASF, 50% ASF/saline, 30% ASF/saline or saline alone, and the three fractions were isolated.
RESULTS: With synovial fluid dilution, there is a statistically significant and consistent depletion of sulfated proteoglycan incorporated into the extracellular matrix (p< 0.0001) and a similar, though less impactful, depletion of secreted proteoglycan (p< 0.01). Matrilin 3, an ECM molecule that is induced in early OA, demonstrated a statistically significant consistent increase in the secreted fraction with increased dilution of the ASF (p< 0.02). Concomitantly, the ECM-associated Matrilin-3 was also significantly increased but only in the saline alone cultures (p< 0.0003). Collagen type II, a natural part of the cartilage ECM that is only produced by chondrocytes, was significantly reduced in the saline only ECM-associated fraction (p< 0.02) and significantly increased in the saline only cell-associated fraction (p< 0.01). These data indicate that cellular damage occurs early when synovial fluid concentrations are altered.
CONCLUSION: Dilution of synovial fluid with saline, as occurs during arthroscopy, induces early alterations in chondrocyte extracellular matrix metabolism consistent with osteoarthritic changes. Increasing dilution led to significant depletion of sulfated proteoglycans from the ECM and increased secretion of Matrilin-3, a marker associated with early OA. These findings suggest that even short-term changes in the cartilage microenvironment can impair matrix homeostasis. Our results support the hypothesis that procedural conditions during arthroscopy may contribute to early cartilage damage and warrant further investigation into protective strategies. Current follow-on studies are designed to mitigate this effect with standard-of-care pharmaceutical interventions, including non-steroidal anti-inflammatory treatment (pre-treatment and concurrent treatment). Overall, this study indicates a need for more thorough investigation of the cellular alterations associated with the standard conditions for exploratory arthroscopy.
Embargo Period
5-21-2026
Extracellular matrix metabolism in chondrocytes reflects early osteoarthritis patterns when reared in diluted synovial fluid: Implications for exploratory arthroscopy
Philadelphia, PA
INTRODUCTION: Arthroscopy is the standard of care and a minimally invasive procedure for diagnosing joint pathologies. But very few studies have been conducted to determine whether procedural conditions may alter chondrocytes in ways that can lead to osteoarthritis (OA). During the procedure, changes occur in the cartilage microenvironment, including diluting the synovial fluid with saline to improve field visibility.
OBJECTIVE: The fundamental question then is whether these temporary conditions contribute to cellular and metabolic changes consistent with early OA pathogenesis and whether concurrent pharmacological intervention can alter this damage.
METHODS: To address the challenge of studying cellular-level effects in vitro, our lab optimized a three-dimensional, serum-free tissue culture model for primary human articular chondrocytes (HC-a) encapsulated in alginate beads at a density of 1.5 x 106 cells/mL of alginate that recreates the cartilage environment. We reared HC-a in varying dilutions of artificial synovial fluid (ASF) and measured key extracellular matrix (ECM) proteins in the secreted (S), ECM-associated (E), and cell-associated (C) fractions. Cells were incubated for 24 hours with 100% ASF, 50% ASF/saline, 30% ASF/saline or saline alone, and the three fractions were isolated.
RESULTS: With synovial fluid dilution, there is a statistically significant and consistent depletion of sulfated proteoglycan incorporated into the extracellular matrix (p< 0.0001) and a similar, though less impactful, depletion of secreted proteoglycan (p< 0.01). Matrilin 3, an ECM molecule that is induced in early OA, demonstrated a statistically significant consistent increase in the secreted fraction with increased dilution of the ASF (p< 0.02). Concomitantly, the ECM-associated Matrilin-3 was also significantly increased but only in the saline alone cultures (p< 0.0003). Collagen type II, a natural part of the cartilage ECM that is only produced by chondrocytes, was significantly reduced in the saline only ECM-associated fraction (p< 0.02) and significantly increased in the saline only cell-associated fraction (p< 0.01). These data indicate that cellular damage occurs early when synovial fluid concentrations are altered.
CONCLUSION: Dilution of synovial fluid with saline, as occurs during arthroscopy, induces early alterations in chondrocyte extracellular matrix metabolism consistent with osteoarthritic changes. Increasing dilution led to significant depletion of sulfated proteoglycans from the ECM and increased secretion of Matrilin-3, a marker associated with early OA. These findings suggest that even short-term changes in the cartilage microenvironment can impair matrix homeostasis. Our results support the hypothesis that procedural conditions during arthroscopy may contribute to early cartilage damage and warrant further investigation into protective strategies. Current follow-on studies are designed to mitigate this effect with standard-of-care pharmaceutical interventions, including non-steroidal anti-inflammatory treatment (pre-treatment and concurrent treatment). Overall, this study indicates a need for more thorough investigation of the cellular alterations associated with the standard conditions for exploratory arthroscopy.